TGF Signaling in Anti-Rejection Drug-Induced NMSC

抗排斥药物诱导的 NMSC 中的 TGF 信号转导

• 批准号: 7504434
• 负责人: ROSEMARY J AKHURST
• 金额: $ 30.91万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-01 至 2008-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7504434
• 关键词: 6-Mercaptopurine; Adopted; Affect; Aftercare; Age; Agreement; Backcrossings; Biological; Biological Models; Cancer Patient; Carcinoma; Cell Line; Characteristics; Common Neoplasm; Complementary DNA; Congenic Mice; Cyclosporine; Cyclosporins; Development; Drug usage; Early Diagnosis; Excision; FK506; Gene Expression; Genes; Genetic; Genetic Polymorphism; Goals; Human Genetics; Immunosuppressive Agents; Individual; Invasive; Invasive Lesion; Investigation; Kidney Transplantation; Knowledge; Life Style; Malignant Epithelial Cell; Malignant Neoplasms; Maps; Mediating; Microarray Analysis; Molecular; Morbidity - disease rate; Mus; Neoplasm Metastasis; Oligonucleotides; Organ Transplantation; Pathway interactions; Patients; Pattern; Penetrance; Pharmaceutical Preparations; Phenotype; Play; Population; Reporter Genes; Resistance; Risk; Risk Assessment; Role; Screening procedure; Series; Signal Pathway; Signal Transduction; Sirolimus; Skin Cancer; Skin Carcinoma; Skin Neoplasms; Susceptibility Gene; TGFB1 gene; Testing; Tissue Microarray; Transgenic Mice; Transplant Recipients; Tumor Cell Invasion; United States; Vascular Endothelial Growth Factors; angiogenesis; cancer risk; drug development; fluorouracil/methotrexate/mitoxantrone protocol; genetic association; genetic risk factor; genetic variant; in vivo; melanoma; mouse model; mycophenolate mofetil; novel; prednisolone; prophylactic; response; sex; tool; tumor; tumor initiation; tumor progression